Study of Weekly ALTU-238 Compared With Daily Nutropin AQ in Prepubertal Children With Growth Hormone Deficiency
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate the safety and effectiveness of ALTU-238 in the
treatment of children with growth hormone deficiency who have not yet reached puberty who
lack the normal ability to make growth hormone themselves. This study will also test if
ALTU-238 works as a weekly treatment.